Inhibition of p53 Transcriptional Activity: A Potential Target for Future Development of Therapeutic Strategies for Primary Demyelination
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Oligodendrogliopathy, microglial infiltration, and lack of remyelination are detected in the brains of patients with multiple sclerosis and are accompanied by high levels of the transcription factor p53. In this study, we used the cuprizone model of demyelination, characterized by oligodendrogliopathy and microglial infiltration, to define the effect of p53 inhibition. Myelin preservation, decreased microglial recruitment, and gene expression were observed in mice lacking p53 or receiving systemic administration of the p53 inhibitor pifithrin-alpha, compared with untreated controls. Decreased levels of lypopolysaccharide-induced gene expression were also observed in vitro, in p53(-/-) primary microglial cultures or in pifithrin-alpha-treated microglial BV2 cells. An additional beneficial effect of lack or inhibition of p53 was observed in Sox2+ multipotential progenitors of the subventricular zone that responded with increased proliferation and oligodendrogliogenesis. Based on these results, we propose transient inhibition of p53 as a potential therapeutic target for demyelinating conditions primarily characterized by oligodendrogliopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · cited 1×
“These premises have led to the therapeutic use of the tetracycline derivative minocycline, an antibiotic with the ability to inhibit the inflammatory response by modulation of the microglial component (Yrjanheikki et al., 1998, 1999; Yong et al., 2004).”
BackgroundMatsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 6×
“The animal model that best recapitulates these neuropathological findings is the cuprizone model of demyelination that is characterized by loss of myelin in the dorsal corpus callosum because of oligodendrocytic death and microglial activation (Matsushima and Morell, 2001).”
BackgroundMethodResultInfluentialNait‐Oumesmar, B., Decker, L., Lachapelle, F., Avellana‐Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00873.x · Cited by 560 · cited 1×
“…also characterized for the presence of the oligodendrocyte precursor surface molecule polysialic acid-neural cell adhesion molecule (PSA-NCAM) (Ben-Hur et al., 1998; Nait-Oumesmar et al., 1999, 2007; Decker et al., 2000), we conducted a similar analysis on the adult SVZ of cuprizone-treated mice.”
MethodThe Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P.-Y., Suzuki, K., & Matsushima, G. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00168-4 · Cited by 459 · cited 5×
“…is well established (Carson, 2002; Kim and de Vellis, 2005; Sanders and De Keyser, 2007), and the studies in the cuprizone model of demyelination (Hiremath et al., 1998; Pasquini et al., 2007) have provided support to the concept that microglial activation might contribute to oligodendrocytic…”
BackgroundMethodInfluentialKotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385 · cited 2×
“, 2002), it is also clear that it has negatively impacted remyelination and repair (Kotter et al., 2001; Li et al., 2005).”
BackgroundInhibition of autoimmune encephalomyelitis by a tetracycline
Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D. (2002) · Annals of Neurology · doi:10.1002/ana.10092 · Cited by 295 · cited 2×
“, 2007) and in experimental autoimmune encephalomyelitis models (Popovic et al., 2002), it is also clear that it has negatively impacted remyelination and repair (Kotter et al.”
BackgroundMurtie, J. C., Zhou, Y.-X., Le, T. Q., Vana, A. C., & Armstrong, R. C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.006 · Cited by 157
Jurevics, H., Largent, C., Hostettler, J., Sammond, D. W., K. Matsushima, G., Amber Kleindienst, Toews, A. D., & Morell, P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00954.x · Cited by 106
Trebst, C., Heine, S., Lienenklaus, S., Lindner, M., Baumgärtner, W., Weiss, S., & Stangel, M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0300-z · Cited by 38 · cited 15×
“Pifithrin- treatment increased the number of proliferating cells in vivo, as assessed by the increased number of Ki67 cells in the SVZ (Fig.”
ResultInfluential
Cited by
Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.004 · Cited by 435
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 430
“…receiving the p53 inhibitor pifithrin are less susceptible to cuprizone-induced demyelination and show an enhanced oligodendrocytic survival (Li et al., 2008). p75NTR is a neurotrophin receptor, which can induce different cellular responses, including cell growth but also apoptosis. p75NTR…”
BackgroundDiscovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Hay, D. A., Fedorov, O., Martin, S., Singleton, D. C., Tallant, C., Wells, C., Picaud, S., Philpott, M., Monteiro, O. P., Rogers, C. M., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412434f · Cited by 277
Marie, C., Clavairoly, A., Frah, M., Hmidan, H., Yan, J., Zhao, C., Van Steenwinckel, J., Daveau, R., Zalc, B., Hassan, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802620115 · Cited by 103
“The Chd7 direct repression of p53/Trp53 in OPCs also has a potential interest in MS becauseMS brain tissues up-regulate p53 expression (48), suggesting that a transient, and if possible brain-restricted, administration of Fig.”
BackgroundIn toxic demyelination oligodendroglial cell death occurs early and is FAS independent
Hesse, A., Wagner, M., Held, J., Brück, W., Salinas-Riester, G., Hao, Z., Waisman, A., & Kuhlmann, T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.016 · Cited by 98
Metadata
- Authors
- Li, J., Ghiani, C. A., Kim, J. Y., Liu, A., Sandoval, J., DeVellis, J., & Casaccia-Bonnefil, P.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-06-11
- Volume
- 28
- Issue
- 24
- Pages
- 6118-6127
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2040599377
- Cited by
- 52
- References
- 10
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of p53 Transcriptional Activity: A Potential Target for Future Development of Therapeutic Strategies for Primary Demyelination. https://app.cochat.ai/papers/10.1523/jneurosci.0184-08.2008
- The paper
- Li, J., Ghiani, C. A., Kim, J. Y., Liu, A., Sandoval, J., DeVellis, J., & Casaccia-Bonnefil, P. (2008). Inhibition of p53 Transcriptional Activity: A Potential Target for Future Development of Therapeutic Strategies for Primary Demyelination. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0184-08.2008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.